MX2021003064A - Formas cristalinas de 6-(1-acriloilpiperidin-4-il)-2-(4-fenoxifeni l)nicotinamida. - Google Patents
Formas cristalinas de 6-(1-acriloilpiperidin-4-il)-2-(4-fenoxifeni l)nicotinamida.Info
- Publication number
- MX2021003064A MX2021003064A MX2021003064A MX2021003064A MX2021003064A MX 2021003064 A MX2021003064 A MX 2021003064A MX 2021003064 A MX2021003064 A MX 2021003064A MX 2021003064 A MX2021003064 A MX 2021003064A MX 2021003064 A MX2021003064 A MX 2021003064A
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline forms
- acryloylpiperidin
- phenoxyphenyl
- nicotinamide
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732994P | 2018-09-18 | 2018-09-18 | |
| PCT/CN2019/106433 WO2020057549A1 (en) | 2018-09-18 | 2019-09-18 | Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021003064A true MX2021003064A (es) | 2021-05-27 |
Family
ID=69888278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021003064A MX2021003064A (es) | 2018-09-18 | 2019-09-18 | Formas cristalinas de 6-(1-acriloilpiperidin-4-il)-2-(4-fenoxifeni l)nicotinamida. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11945792B2 (https=) |
| EP (1) | EP3853217B1 (https=) |
| JP (1) | JP2022501351A (https=) |
| KR (1) | KR20210060501A (https=) |
| CN (2) | CN112654607B (https=) |
| AU (1) | AU2019341284B2 (https=) |
| CA (1) | CA3111114A1 (https=) |
| ES (1) | ES2951420T3 (https=) |
| MX (1) | MX2021003064A (https=) |
| SG (1) | SG11202102116XA (https=) |
| WO (1) | WO2020057549A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115894440B (zh) * | 2022-10-27 | 2024-10-22 | 都创(重庆)医药科技有限公司 | 奥布替尼化合物的晶型及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015028662A1 (en) | 2013-08-30 | 2015-03-05 | Consejo Superior De Investigaciones Cientificas (Csic) | Compositions and methods for characterization and amelioration of rheumatoid arthritis |
| KR102272792B1 (ko) * | 2013-09-30 | 2021-07-05 | 광저우 이노케어 파마 테크 씨오., 엘티디. | Ｂｔｋ의 치환된 니코틴이미드 저해제 및 그의 제조 방법 및 암, 염증 및 자가면역 질환에의 용도 |
| SG11201704808VA (en) * | 2014-12-18 | 2017-07-28 | Principia Biopharma Inc | Treatment of pemphigus |
| US20180193274A1 (en) * | 2014-12-24 | 2018-07-12 | Principia Biopharma Inc. | Compositions for ileo-jejunal drug delivery |
-
2019
- 2019-09-18 AU AU2019341284A patent/AU2019341284B2/en active Active
- 2019-09-18 KR KR1020217009903A patent/KR20210060501A/ko not_active Ceased
- 2019-09-18 ES ES19862150T patent/ES2951420T3/es active Active
- 2019-09-18 CN CN201980058360.8A patent/CN112654607B/zh active Active
- 2019-09-18 JP JP2021515106A patent/JP2022501351A/ja active Pending
- 2019-09-18 WO PCT/CN2019/106433 patent/WO2020057549A1/en not_active Ceased
- 2019-09-18 SG SG11202102116XA patent/SG11202102116XA/en unknown
- 2019-09-18 MX MX2021003064A patent/MX2021003064A/es unknown
- 2019-09-18 EP EP19862150.0A patent/EP3853217B1/en active Active
- 2019-09-18 CN CN202211635896.1A patent/CN116496247A/zh active Pending
- 2019-09-18 CA CA3111114A patent/CA3111114A1/en active Pending
-
2021
- 2021-03-03 US US17/191,310 patent/US11945792B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022501351A (ja) | 2022-01-06 |
| CN116496247A (zh) | 2023-07-28 |
| AU2019341284A1 (en) | 2021-04-15 |
| CN112654607B (zh) | 2023-01-13 |
| CA3111114A1 (en) | 2020-03-26 |
| EP3853217A1 (en) | 2021-07-28 |
| WO2020057549A1 (en) | 2020-03-26 |
| EP3853217B1 (en) | 2023-06-07 |
| US11945792B2 (en) | 2024-04-02 |
| CN112654607A (zh) | 2021-04-13 |
| AU2019341284B2 (en) | 2024-09-05 |
| KR20210060501A (ko) | 2021-05-26 |
| SG11202102116XA (en) | 2021-04-29 |
| ES2951420T3 (es) | 2023-10-20 |
| US20210188801A1 (en) | 2021-06-24 |
| EP3853217A4 (en) | 2022-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017008520A (es) | Compuestos de pirimidina fusionada para el tratamiento del virus de inmunodeficiencia humana (vih). | |
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| PH12018501151A1 (en) | Tank-binding kinase inhibitor compounds | |
| MY210123A (en) | Tlr7/8 antagonists and uses thereof | |
| MX2017008518A (es) | Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih). | |
| PH12019550235A1 (en) | Kinase inhibitors and uses thereof | |
| MD4650B1 (ro) | Derivaţi de chinazolină utilizaţi în tratamentul HIV | |
| SG11202103823PA (en) | Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors | |
| SG10201811384TA (en) | Mnk inhibitors and methods related thereto | |
| MX2018001990A (es) | Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac. | |
| MX378732B (es) | Formas solidas novedosas | |
| EP4279071A3 (en) | Novel cannabinoid formulations | |
| MX2020001793A (es) | Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos. | |
| AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
| NZ725917A (en) | Novel polymerase-i inhibitors, uses and methods for making them | |
| PH12017500732B1 (en) | Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidine-2,4-diamine | |
| PH12019501362B1 (en) | Polymorphs | |
| MX2019005855A (es) | Formulaciones que se pueden pulverizar. | |
| MX2018000515A (es) | Compuestos fluorados de cbd, composiciones y usos de los mismos. | |
| MY188420A (en) | Crystalline forms of (s)-afoxolaner | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| NZ742952A (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
| PH12017500451A1 (en) | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl) oxy)-n, 2-dimethylbenzofuran -3- carboxamide | |
| MX2019004580A (es) | Formulaciones farmaceuticas y metodos para prepararlas. | |
| MX2017011116A (es) | Composiciones novedosas, usos y metodos para hacerlas. |